- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medistim ASA (MEDI)
The Medistim share price today is 230.00 %REPORT_CURRENCY%, view OL MEDI stock exchange data. Track the latest Medistim share price with real-time updates on MEDI stock performance including market cap, day range, 52-week range and dividend yield. Access MEDI charts, earnings dates and analyst estimates to support your investment decisions.
230.00
0.00(0.00%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
226.00
238.00
52 wk Range
157.00
292.00
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
226.00238.00
52 wk Range
157.00292.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.46%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MEDI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
310.00
Upside
+34.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has maintained dividend payments for 22 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Neutral
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in a single system for vascular surgery; MiraQ Ultimate that combines TTFM and ultrasound imaging in a single system for cardiac, vascular, and transplant surgery; and imaging probes for intraoperative use. It also provides QuickFit TTFM probes, which are designed to hold the vessel and ensure precise measurements on various types of vessel grafts; Vascular TTFM probes for locking slide mechanism designed to secure the vessel while minimizing the manipulation; ultrasound imaging probes; and Doppler probes that are used to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, the company distributes and sells third party medical equipment. Medistim ASA was founded in 1984 and is headquartered in Oslo, Norway.
Medistim ASA Earnings Call Summary for Q3/2025
- Revenue up 25.7% YoY to NOK 166.8M, slightly below forecast. EBIT grew 27.1% to NOK 40.6M. Stock rose 4.76% post-earnings.
- Imaging systems now 50% of total system sales. U.S. market supports 37% of CABG procedures, remains key growth driver.
- Gross margin improved to 81.5%. Profit after tax up 48% YoY to NOK 34.7M. Company exploring direct sales in France and Japan.
- CEO highlights Asia-Pacific as medium to long-term growth engine. Vascular market growth slowed to 3.7%, presenting a challenge.
- Analysts queried market acceptance of price increases, quarterly performance variations, and potential geographic expansion plans.
Last Updated: 24-10-2025, 01:48 pm
Read Full TranscriptCompare MEDI to Peers and Sector
Metrics to compare | MEDI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 26.4x | 17.3x | −0.4x | |
PEG Ratio | 0.49 | −0.07 | 0.00 | |
Price/Book | 9.0x | 1.9x | 2.6x | |
Price / LTM Sales | 6.0x | 2.6x | 3.2x | |
Upside (Analyst Target) | 34.8% | 32.0% | 46.7% | |
Fair Value Upside | Unlock | 19.6% | 7.6% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 310.00
(+34.78% Upside)
Earnings
Latest Release
27-02-2026
EPS / Forecast
2.09 / 1.51
Revenue / Forecast
182M / 175M
FAQ
What Is the Medistim (MEDI) Share Price Today?
The Medistim share price today is 230.00 NOK.
What is the current Medistim (MEDI) share price and day range?
As of 24-04-2026, the Medistim share price is 230.00 NOK, with a previous close of 230.00 NOK. The share price has ranged from 226.00 to 238.00 NOK today, while the 52-week range spans from 157.00 to 292.00 NOK.
What Is the Medistim Market Cap?
As of today, Medistim market cap is 4.24B.
Does Medistim Pay Dividends? What's The Current Dividend Yield?
The Medistim dividend yield is 3.46%.
What Is the Medistim (MEDI) Share Price Target?
The average 12-month share price target for Medistim is 310.00 NOK, with a high estimate of 310 NOK and a low estimate of 310 NOK. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Strong Buy and +34.78% Upside potential.
What Is Medistim's Earnings Per Share (TTM)?
The Medistim EPS (TTM) is 8.71.
When Is the Next Medistim Earnings Date?
Medistim will release its next earnings report on 07-05-2026.
From a Technical Analysis Perspective, Is MEDI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
What Stock Exchange Does Medistim Trade On?
Medistim is listed and trades on the Oslo Stock Exchange.
What Is the Stock Symbol for Medistim?
The stock symbol for Medistim is "MEDI."
How Many Times Has Medistim Stock Split?
Medistim has split 0 times.
How Many Employees Does Medistim Have?
Medistim has 159 employees.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.